This compound is a phosphonate intermediate specifically designed for the synthesis of antiviral prodrugs. Its structure features a purine base and a phosphonate ester group, which are key to its role in pharmaceutical manufacturing.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 379270-35-6
9-[(2R)-2-(diphenoxyphosphorylmethoxy)propyl]purin-6-amine
Tenofovir alafenamide impurity
테노포비르 디소프록실
active pharmaceutical ingredient
Tenofovir hydrate
active pharmaceutical ingredient
5-Methyl-3,4-diphenyl-isoxazole
Pharmaceutical intermediate for parecoxib
4-phenoxyphthalic acid
pharmaceutical intermediate
3-(Trifluoromethyl)pyridine
Pharmaceutical intermediate
4-Oxoretinoic acid
retinoid metabolite intermediate
TENOFOVIR ALAFENAMIDE
Active pharmaceutical ingredient
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-phenoxyphosphinic acid
ITAMCOCNZJPJDF-LLVKDONJSA-N
C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)OC3=CC=CC=C3